著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Paolo Neviani and Jason G. Harb and Joshua J. Oaks and Ramasamy Santhanam and Christopher J. Walker and Justin J. Ellis and Gregory Ferenchak and Adrienne M. Dorrance and Carolyn A. Paisie and Anna M. Eiring and Yihui Ma and Hsiaoyin C. Mao and Bin Zhang and Mark Wunderlich and Philippa C. May and Chaode Sun and Sahar A. Saddoughi and Jacek Bielawski and William Blum and Rebecca B. Klisovic and Janelle A. Solt and John C. Byrd and Stefano Volinia and Jorge Cortes and Claudia S. Huettner and Steffen Koschmieder and Tessa L. Holyoake and Steven Devine and Michael A. Caligiuri and Carlo M. Croce and Ramiro Garzon and Besim Ogretmen and Ralph B. Arlinghaus and Ching-Shih Chen and Robert Bittman and Peter Hokland and Denis-Claude Roy and Dragana Milojkovic and Jane Apperley and John M. Goldman and Alistair Reid and James C. Mulloy and Ravi Bhatia and Guido Marcucci and Danilo Perrotti,PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells,Journal of Clinical Investigation,0021-9738,American Society for Clinical Investigation,2013-09-03,123,10,4144-4157,https://cir.nii.ac.jp/crid/1360292621210505088,https://doi.org/10.1172/jci68951